Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Effectiveness in Real-World Clinical Practice, as Well as the Safety and Adherence to Therapy With a Fixed-Dose Combination of Amlodipine and Valsartan

NCT07847970 is registered in ClinicalTrials.gov with VIVA PHARM LLP as lead sponsor.

NCT NCT07847970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Effectiveness in Real-World Clinical Practice, as Well as the Safety and Adherence to Therapy With a Fixed-Dose Combination of Amlodipine and Valsartan
Lead sponsor
VIVA PHARM LLP
Phase
Observational
Overall status
Active, not recruiting
Start date
November 20, 2025
Completion date
November 20, 2026
Enrollment
216 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), hypertension